Navigation Links
Distinguished Cancer Investigator, Daniel Von Hoff, M.D., to Lead Cell Therapeutics' Scientific Advisory Board
Date:7/23/2013

SEATTLE, July 24, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that Daniel D. Von Hoff, M.D., F.A.C.P, a  leading medical oncologist who has been the lead investigator in the development of important oncology therapeutics, will serve as Chairman of CTI's Scientific Advisory Board. The purpose of the Scientific Advisory Board will be to assist management in the strategic development of its oncology portfolio and clinical trial design; work with business development on in-licensing and out-licensing opportunities, and assist in the use of translational and personalized approaches to therapeutic targets.

Dr. Von Hoff is currently Physician in Chief and Director of Translational Research at the Translational Genomics Research Institute (TGen), Chief Scientific Officer for US Oncology and for Scottsdale Healthcare's Clinical Research Institute.  Dr. Von Hoff's major interest is in the development of new anticancer agents, both in the clinic and in the laboratory.  An internationally recognized innovator in the development of targeted therapies, he and his colleagues were involved in the development of many approved therapeutic agents that are now used routinely, including paclitaxel, docetaxel, mitoxantrone, fludarabine, clofarabine, alemtuzumab, irinotecan, nelarabine, capecitabine, and vismodegib.  Dr. Von Hoff's laboratory interests and contributions have been in the area of using translational and genomic approaches to individualize therapy for cancer.  His laboratory is now concentrating on discovering new targets in pancreatic cancer.

"I am pleased to help build and lead CTI's Scientific Advisory Board, as I am very impressed with the diversity of the CTI portfolio of product candidates and their potential as targeted therapies
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Distinguished Health Group Speaks about Swissray Benefits
2. Lillys Team Solutions and Solutions for Wellness Resources for Serious Mental Illness Added to SAMHSAs Distinguished National Registry
3. Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To Board Of Directors
4. PharmaNet/i3 Receives Distinguished Partner Award from the US Chinese Anti-Cancer Association
5. AACC Annual Meeting Breaking Science Includes New Tests to Detect Life-Threatening Prostate Cancer, New Cystic Fibrosis Tests That Can Be Measured at the Point of Care, and New Ways to Determine the Safety of Drugs Used to Treat Schizophrenia and Bi
6. Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
7. In Terms of Effect on Overall Survival, Current and Emerging Therapies Have No Advantage Over Avastin/FOLFIRI in the Treatment of Second-Line Metastatic Colorectal Cancer, According to Clinical Data and Thought Leader Opinion
8. Protein Targeted For Cancer Drug Development Is Essential For Normal Heart Function
9. Surefire Infusion System Found Safe and Effective for Delivery of 90Y in Treating Inoperable Liver Cancer
10. Link Between Cancer and Obesity Argues for More Aggressive Treatments, says Dr. Feiz & Associates
11. TREATMENT OF PRIMARY LIVER CANCER: SARAH STUDY NOW AVAILABLE FOR ALL ELIGIBLE PATIENTS THROUGHOUT FRANCE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  MedAptus® today announced ... designed to simplify pre-care needs for busy inpatient ... to automatically assign patients to hospitalists or other ... care and other requirements such as ensuring patient ... In ...
(Date:3/30/2015)... CHARLOTTE, N.C. , March 30, 2015 /PRNewswire/ ... today announced a worldwide search for product innovations ... The most promising ideas uncovered during the 8-week ... partners for potential commercialization.  Invention ideas can be ... www.EdisonNationMedical.com/Mobility now through May 28, 2015. ...
(Date:3/30/2015)... International Inc. (OTCQB: NUIN) ("Nutrastar" or the "Company"), a ... including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages ... for the full year ended December 31, 2014. ... December 31, 2014   , Net ... in full year 2013. , Gross ...
Breaking Medicine Technology:MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3Nutrastar International, Inc. Announces Full Year 2014 Results 2Nutrastar International, Inc. Announces Full Year 2014 Results 3Nutrastar International, Inc. Announces Full Year 2014 Results 4Nutrastar International, Inc. Announces Full Year 2014 Results 5Nutrastar International, Inc. Announces Full Year 2014 Results 6Nutrastar International, Inc. Announces Full Year 2014 Results 7Nutrastar International, Inc. Announces Full Year 2014 Results 8Nutrastar International, Inc. Announces Full Year 2014 Results 9
(Date:3/30/2015)... “ iCareTech ” was featured on NewsWatch as ... at the latest and coolest technology products and services available ... expert, conducted the review and shared with viewers how this ... medical and health fields. , Wearable technology has been one ... couple of years. Well, at CES, NewsWatch TV came across ...
(Date:3/30/2015)... Innovaacom, a leading provider of medical education ... is expanding its services into Asia in 2015. Innovaacom’s ... world comes at a time when Asia’s strengthening economy ... healthcare. A rapidly growing aging population and changing socio-economic ... medicine in Asia. “We are excited to be a ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 In a ... March 17th, Governor Chris Christie is championing effective drug ... disorders.New Jersey is scrambling to recover funds to stabilize ... best care for victims of drug and alcohol addiction. ... to those plagued by substance use disorders in New ...
(Date:3/30/2015)... This report studies the global tumor ... to 2019. , Based on the type of ... into four major segments, namely radio-frequency, microwave, cryoablation ... and laser ablation) segments. Moreover, based on type ... classified into three segments, namely, interventional radiology, surgery ...
(Date:3/30/2015)... 2015 Tel-Aviv – March 30, 2015 ... announced the closing of $12.5 million in new financing ... Viola Group. The funding will further GlassesUSA's aggressive business ... in the growing global market of online eyewear, both ... by CEO Daniel Rothman, COO Eldad Rothman, and CTO ...
Breaking Medicine News(10 mins):Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... easy access to alcohol-based handrubs can improve hygiene in ... Access journal Critical Care suggests. ,Good ... the spread of infections within hospitals. Alcohol-based handrubs are ... amongst hospital staff remains low. ,One of ...
... improved after one month on cholesterol-lowering drugs called statins ... to research that will be presented at the ... April 28 May 5, 2007. ,The ... of having a stroke or transient ischemic attack, or ...
... supply of stem cells that can repair the most severe ... These reservists normally lie around and do nothing, but ... jump into action. A report on the discovery will appear ... ,These stem cells act like the Army Reserves of ...
... tower and research at the Baltimore institution Johns Hopkins ... Hopkins Medicine from His Highness Sheikh Khalifa bin ... Emirates (UAE). Most of the gift, made in honor ... Al Nahyan, will support construction of The Johns Hopkins ...
... radio or the cell phone on the car seat next to ... turn up the dial or take a call while maneuvering ... for young drivers with Attention Deficit/Hyperactivity Disorder (ADHD). ... more likely to have a car accident than non-ADHD drivers. Daniel ...
... their first televised debate -- held at the Ronald ... -- fielded questions about their views on abortion rights, ... reports. ,The 90-minute debate included Sens. ... York City Mayor Rudolph Giuliani; former Virginia Gov. James ...
Cached Medicine News:Health News:When Smell Cells Fail They Call In Stem Cell Reserves 2Health News:Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan 2Health News:Johns Hopkins Medicine Honors U.A.E. Sheikh Zayed Bin Sultan Al Nahyan 3Health News:Researchers To Test Whether ADHD Medication Helps Young Adults While Driving 2Health News:Republican Presidential Candidates Discuss Abortion, Stem Cells as Part of First Debate 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000) ...
Medicine Products: